Purpose: We developed the ureteral stent symptom questionnaire (USSQ), a psychometrically valid measure to evaluate symptoms and impact on quality of life of ureteral stents.
Materials and methods: A total of 309 patients were asked to participate during different phases of our study. In phase 1 a structured literature search, 9 patient interviews and studies of 90 patients using existing instruments formed the foundation for the initial draft of our new questionnaire. In phase 2 the USSQ was pilot tested, reviewed by experts and field tested in 40 patients to produce a final 38-item draft. In phase 3 formal validation studies were performed in 55 patients to assess validity, reliability and sensitivity to change. Discriminant validation was performed by administering the questionnaire to 3 groups of patients without stents.
Results: The final draft addressed various domains of health (6 sections and 38 items) affected by stents covering urinary symptoms, pain, general health, work performance, sexual matters and additional problems. The validation studies showed the questionnaire to be internally consistent (Cronbach's alpha > 0.7) with good test-retest reliability (Pearson's coefficient > 0.84). The questionnaire demonstrated good construct validity and sensitivity to change shown by significant changes in the score with and after removal of stents. The new USSQ discriminated patients with stents from healthy controls (p < 0.001) and patients with urinary calculi without stents and lower urinary tract symptoms.
Conclusions: Indwelling ureteral stents have a significant impact on health related quality of life. The new USSQ is a valid and reliable instrument that is expected to become a standard outcome measure to evaluate the impact and compare different types of stents.
Giannarini G, Keeley FX Jr, Valent F, Milesi C, Mogorovich A, Manassero F, Barbone F, Joshi HB, Timoney AG, Selli C. Giannarini G, et al. J Urol. 2008 Aug;180(2):624-8. doi: 10.1016/j.juro.2008.04.022. Epub 2008 Jun 12. J Urol. 2008. PMID: 18554654
Joshi HB, Chitale SV, Nagarajan M, Irving SO, Browning AJ, Biyani CS, Burgess NA. Joshi HB, et al. J Urol. 2005 Dec;174(6):2303-6. doi: 10.1097/01.ju.0000181815.63998.5f. J Urol. 2005. PMID: 16280829 Clinical Trial.
Leibovici D, Cooper A, Lindner A, Ostrowsky R, Kleinmann J, Velikanov S, Cipele H, Goren E, Siegel YI. Leibovici D, et al. Isr Med Assoc J. 2005 Aug;7(8):491-4. Isr Med Assoc J. 2005. PMID: 16106772
Lamb AD, Vowler SL, Johnston R, Dunn N, Wiseman OJ. Lamb AD, et al. BJU Int. 2011 Dec;108(11):1894-902. doi: 10.1111/j.1464-410X.2011.10170.x. Epub 2011 Mar 31. BJU Int. 2011. PMID: 21453351 Review.
Van Besien J, Keller EX, Somani B, Pietropaolo A, Claessens M, Merckx L, Tailly T, De Coninck V. Van Besien J, et al. Eur Urol Focus. 2022 Jul;8(4):1031-1041. doi: 10.1016/j.euf.2021.10.002. Epub 2021 Oct 20. Eur Urol Focus. 2022. PMID: 34688588 Review.
Liu R, Wan Z, Zhang Y. Liu R, et al. Int Urol Nephrol. 2024 Aug 31. doi: 10.1007/s11255-024-04193-4. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39215855
Pricop C, Bandac CA, Ivanuță M, Rădăvoi D, Jinga V, Puia D. Pricop C, et al. J Clin Med. 2024 Jul 22;13(14):4278. doi: 10.3390/jcm13144278. J Clin Med. 2024. PMID: 39064317 Free PMC article.
Liu M, Liu S, Mao Q, Zou Q, Cui Y, Wu J. Liu M, et al. PLoS One. 2024 May 3;19(5):e0302716. doi: 10.1371/journal.pone.0302716. eCollection 2024. PLoS One. 2024. PMID: 38701097 Free PMC article.
Lim EJ, Choo ZW, Mangat R, Durai P, Biligere S, Tan Y, Yeung Marcus LH, Seet Li Ting NA, Heng CT, Ferreti S, Gauhar V. Lim EJ, et al. Asian J Urol. 2024 Apr;11(2):324-330. doi: 10.1016/j.ajur.2022.03.013. Epub 2022 Oct 1. Asian J Urol. 2024. PMID: 38680586 Free PMC article.
Edison E, Mazzon G, Arumuham V, Choong S. Edison E, et al. Asian J Urol. 2024 Apr;11(2):180-190. doi: 10.1016/j.ajur.2023.04.003. Epub 2023 Jul 27. Asian J Urol. 2024. PMID: 38680580 Free PMC article. Review.